This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
in patients with | 600 |
acquired pneumonia in | 319 |
the presence of | 274 |
the most common | 264 |
lower respiratory tract | 263 |
of patients with | 246 |
the management of | 246 |
the use of | 213 |
the diagnosis of | 203 |
respiratory syncytial virus | 197 |
times a day | 189 |
years of age | 187 |
as well as | 178 |
the treatment of | 177 |
pneumonia in children | 171 |
of pneumonia in | 171 |
risk factors for | 166 |
patients with severe | 164 |
pneumonia in adults | 163 |
guidelines for the | 158 |
for the management | 154 |
the united states | 152 |
in children with | 151 |
patients with pneumonia | 150 |
pneumonia in the | 149 |
one of the | 149 |
patients with cap | 149 |
patients with community | 147 |
intensive care unit | 140 |
respiratory tract infections | 139 |
of the lung | 138 |
in the united | 133 |
diagnosis of pneumonia | 126 |
the incidence of | 123 |
community acquired pneumonia | 121 |
the development of | 119 |
for patients with | 118 |
should be considered | 117 |
is the most | 114 |
the number of | 109 |
based on the | 106 |
in the lung | 106 |
the risk of | 105 |
infectious diseases society | 103 |
society of america | 103 |
polymerase chain reaction | 102 |
severe acute respiratory | 102 |
respiratory distress syndrome | 102 |
respiratory tract infection | 101 |
a systematic review | 101 |
management of community | 101 |
in addition to | 100 |
is characterized by | 99 |
e times a | 98 |
because of the | 94 |
diseases society of | 90 |
twice a day | 90 |
is associated with | 90 |
for the treatment | 88 |
acute respiratory syndrome | 87 |
acute respiratory distress | 86 |
the role of | 86 |
the absence of | 84 |
of the lungs | 84 |
for the diagnosis | 84 |
there is no | 82 |
pneumonia caused by | 82 |
morbidity and mortality | 81 |
according to the | 81 |
of the disease | 81 |
with or without | 80 |
as a result | 80 |
invasive pneumococcal disease | 79 |
the respiratory tract | 79 |
once a day | 79 |
in the treatment | 78 |
associated with a | 76 |
children with pneumonia | 76 |
systematic review and | 73 |
of the most | 73 |
the onset of | 72 |
in the elderly | 71 |
admitted to the | 71 |
cause of death | 71 |
in cases of | 70 |
upper respiratory tract | 70 |
hospitalized patients with | 69 |
can be used | 69 |
the severity of | 69 |
with severe pneumonia | 69 |
of childhood pneumonia | 68 |
review and meta | 67 |
world health organization | 67 |
the time of | 66 |
it is important | 65 |
of children with | 64 |
a result of | 64 |
a and b | 64 |
in the lungs | 63 |
of pneumonia and | 63 |
of the respiratory | 63 |
of streptococcus pneumoniae | 63 |
obstructive pulmonary disease | 62 |
the basis of | 61 |
pneumococcal conjugate vaccine | 61 |
there is a | 61 |
due to the | 61 |
of viral pneumonia | 60 |
chronic obstructive pulmonary | 60 |
should be selected | 60 |
american thoracic society | 60 |
on the basis | 60 |
the results of | 60 |
at the time | 60 |
patients with a | 59 |
of pneumococcal pneumonia | 59 |
more likely to | 58 |
g e times | 58 |
combination therapy with | 58 |
in order to | 58 |
risk of death | 57 |
review of the | 57 |
is caused by | 57 |
is important to | 57 |
the majority of | 56 |
should be performed | 56 |
in patients who | 56 |
of bacterial pneumonia | 56 |
the impact of | 56 |
in the diagnosis | 56 |
in those with | 55 |
in hospitalized patients | 55 |
such as the | 55 |
was associated with | 54 |
bacteremic pneumococcal pneumonia | 54 |
the need for | 54 |
up to of | 54 |
present in the | 54 |
has been reported | 54 |
be considered in | 54 |
drugs should be | 53 |
a cause of | 53 |
is a common | 53 |
the course of | 53 |
referred to as | 53 |
a variety of | 53 |
are associated with | 53 |
of lower respiratory | 53 |
common cause of | 53 |
be used to | 52 |
mg kg times | 52 |
the detection of | 52 |
of influenza a | 52 |
kg times a | 52 |
in this study | 51 |
patients who are | 51 |
the etiology of | 51 |
should be used | 51 |
critically ill patients | 51 |
in the community | 51 |
of antimicrobial drugs | 50 |
increased risk of | 50 |
is one of | 50 |
of communityacquired pneumonia | 50 |
likely to be | 50 |
has not been | 50 |
and management of | 50 |
mg twice a | 50 |
in the absence | 50 |
depending on the | 50 |
in some cases | 49 |
for detection of | 49 |
patients hospitalized with | 49 |
the lower respiratory | 49 |
patients admitted to | 48 |
the cause of | 48 |
infection of the | 48 |
it is not | 48 |
with severe cap | 48 |
from patients with | 48 |
influenza a virus | 48 |
the most important | 48 |
been shown to | 48 |
be associated with | 48 |
similar to those | 48 |
pneumonia is a | 47 |
the pathogenesis of | 47 |
the differential diagnosis | 47 |
in elderly patients | 47 |
is an important | 47 |
herpes simplex virus | 47 |
the effect of | 47 |
pneumococcal pneumonia in | 47 |
the intensive care | 47 |
the prevalence of | 46 |
in infants and | 46 |
therapy should be | 46 |
in many cases | 46 |
to be a | 46 |
pneumonia and influenza | 46 |
pneumonia due to | 46 |
for disease control | 46 |
cases in which | 46 |
drugs to be | 45 |
a h n | 45 |
the lack of | 45 |
of community acquired | 45 |
etiology of pneumonia | 45 |
the proportion of | 45 |
of the following | 44 |
the most frequent | 44 |
management of adults | 44 |
have been reported | 44 |
an increase in | 44 |
caused by a | 44 |
in our study | 44 |
of the lower | 44 |
part of the | 44 |
of adults with | 44 |
it may be | 44 |
viral and bacterial | 44 |
etiology of community | 43 |
younger than years | 43 |
has also been | 43 |
resistant staphylococcus aureus | 43 |
in a patient | 43 |
children younger than | 43 |
infants and children | 43 |
of the chest | 43 |
of severe pneumonia | 43 |
influenza a and | 43 |
some of the | 43 |
as a cause | 42 |
among patients with | 42 |
the infectious diseases | 42 |
a number of | 42 |
to be recommended | 42 |
to the icu | 42 |
there was no | 42 |
should be administered | 42 |
control and prevention | 42 |
the result of | 42 |
in accordance with | 42 |
the type of | 42 |
been associated with | 42 |
randomized controlled trial | 41 |
is difficult to | 41 |
of aspiration pneumonia | 41 |
leading cause of | 41 |
the possibility of | 41 |
can be seen | 41 |
found in the | 41 |
may not be | 41 |
type ii pneumonocytes | 41 |
with respect to | 41 |
and treatment of | 41 |
associated pneumonia in | 41 |
of pneumonia is | 41 |
a patient with | 41 |
pneumonia in a | 41 |
in developing countries | 41 |
white blood cell | 41 |
disease control and | 40 |
months of age | 40 |
severity of illness | 40 |
can also be | 40 |
at least one | 40 |
the nasal cavity | 40 |
the administration of | 39 |
with bacterial pneumonia | 39 |
for diagnosis of | 39 |
the identification of | 39 |
in intensive care | 39 |
in up to | 39 |
should not be | 39 |
disease caused by | 39 |
analysis of the | 39 |
of the patients | 39 |
than years of | 39 |
in the us | 38 |
the lower lobes | 38 |
bacterial and viral | 38 |
it should be | 38 |
prospective study of | 38 |
in cystic fibrosis | 38 |
evaluation of the | 38 |
respiratory infections in | 38 |
may also be | 38 |
be seen in | 38 |
on the other | 37 |
clinical management of | 37 |
and safety of | 37 |
patients who have | 37 |
centers for disease | 37 |
factors associated with | 37 |
included in the | 37 |
in the upper | 37 |
the upper respiratory | 37 |
pneumonia in patients | 37 |
in the uk | 37 |
length of stay | 37 |
must be considered | 37 |
in adult patients | 37 |
diagnosis and treatment | 37 |
should be given | 37 |
should also be | 37 |
the prevention of | 37 |
role in the | 37 |
may lead to | 37 |
the introduction of | 37 |
most common cause | 37 |
the chest radiograph | 37 |
been reported in | 36 |
for treatment of | 36 |
to the hospital | 36 |
patients with influenza | 36 |
hospitalized with community | 36 |
the duration of | 36 |
patients with chronic | 36 |
cases of pneumonia | 36 |
therapy with a | 36 |
a review of | 36 |
of the nasal | 36 |
elderly patients with | 36 |
pneumonia in hospitalized | 36 |
british thoracic society | 36 |
the other hand | 36 |
signs and symptoms | 35 |
clinical practice guidelines | 35 |
are the most | 35 |
there are no | 35 |
severe pneumonia in | 35 |
a chest radiograph | 35 |
may be seen | 35 |
in of patients | 35 |
urinary antigen test | 35 |
in immunocompromised patients | 35 |
in which the | 35 |
in the past | 35 |
a prospective study | 35 |
in young children | 35 |
of cap in | 35 |
avian influenza a | 35 |
appears to be | 35 |
in children and | 35 |
of the clinical | 35 |
respiratory tract disease | 35 |
patients with acute | 35 |
in the early | 35 |
a combination of | 35 |
cause of pneumonia | 35 |
onset of symptoms | 34 |
caused by the | 34 |
seen in the | 34 |
comprehensive molecular testing | 34 |
it has been | 34 |
of the cases | 34 |
diagnosis and management | 34 |
tract infections in | 34 |
of cases of | 34 |
of severe acute | 34 |
a history of | 34 |
in the presence | 34 |
associated with the | 34 |
and mortality in | 34 |
congestive heart failure | 34 |
has been shown | 34 |
risk factor for | 34 |
adult patients with | 34 |
increase in the | 34 |
in the immunocompromised | 34 |
communityacquired pneumonia in | 34 |
in the management | 34 |
the degree of | 34 |
of the manuscript | 34 |
in the first | 34 |
influenza a h | 34 |
acute lower respiratory | 34 |
causes of pneumonia | 33 |
secondary bacterial pneumonia | 33 |
infectious diseases in | 33 |
infections in children | 33 |
clinical features of | 33 |
blood cell count | 33 |
is based on | 33 |
to be the | 33 |
most of the | 33 |
in children aged | 33 |
pneumonia requiring hospitalization | 33 |
respiratory infectious diseases | 33 |
in most cases | 33 |
with acute respiratory | 33 |
acute igg als | 33 |
acquired pneumonia and | 33 |
influenzae type b | 33 |
in children in | 33 |
but it is | 33 |
areas of consolidation | 33 |
of mechanical ventilation | 33 |
a total of | 33 |
of antibiotic therapy | 33 |
respiratory syndrome coronavirus | 33 |
acute lung injury | 33 |
the pleural space | 33 |
management of patients | 33 |
mg once a | 32 |
admitted to hospital | 32 |
were associated with | 32 |
in contrast to | 32 |
in severe cases | 32 |
with influenza a | 32 |
similar to that | 32 |
antimicrobial drugs should | 32 |
there may be | 32 |
in the icu | 32 |
patients with suspected | 32 |
be considered for | 32 |
more common in | 32 |
in the nasal | 32 |
be caused by | 32 |
differential diagnosis of | 32 |
need to be | 32 |
in human beings | 32 |
efficacy and safety | 32 |
igg als to | 32 |
likely to have | 32 |
patients should be | 32 |
related to the | 32 |
and can be | 31 |
acquired pneumonia requiring | 31 |
changes in the | 31 |
pneumonia is the | 31 |
adults with community | 31 |
to those of | 31 |
virus infection in | 31 |
the spectrum of | 31 |
considered to be | 31 |
in the tropics | 31 |
in critically ill | 31 |
the importance of | 31 |
with pneumococcal pneumonia | 31 |
in the intensive | 31 |
be treated with | 31 |
of america american | 31 |
of type ii | 31 |
of the alveolar | 31 |
the burden of | 31 |
incidence of pneumonia | 31 |
of these patients | 31 |
drug should be | 31 |
america american thoracic | 31 |
antimicrobial drug therapy | 31 |
acute respiratory failure | 31 |
of respiratory viruses | 31 |
pneumococcal pneumonia and | 31 |
secondary bacterial infections | 31 |
the diagnosis and | 30 |
number of patients | 30 |
in the lower | 30 |
infections in the | 30 |
and outcomes of | 30 |
of death in | 30 |
diagnosis of pneumococcal | 30 |
to determine the | 30 |
the lung parenchyma | 30 |
and it is | 30 |
pneumococcal conjugate vaccination | 30 |
adults hospitalized with | 30 |
the disease is | 30 |
is defined as | 30 |
of causative microorganisms | 30 |
central nervous system | 30 |
under years of | 30 |
of respiratory tract | 30 |
in children younger | 30 |
as part of | 30 |
of the upper | 30 |
detection of streptococcus | 30 |
a diagnosis of | 29 |
iv q h | 29 |
should be treated | 29 |
and severity of | 29 |
in the study | 29 |
antibiotic therapy for | 29 |
children under years | 29 |
pneumonia severity index | 29 |
and those with | 29 |
characterized by a | 29 |
on the management | 29 |
of resistant bacteria | 29 |
in these patients | 29 |
guidelines on the | 29 |
the efficacy of | 29 |
the age of | 29 |
a reduction in | 29 |
have shown that | 29 |
in terms of | 29 |
in pediatric patients | 29 |
pneumococcal polysaccharide vaccine | 29 |
the usefulness of | 29 |
the lungs are | 29 |
for more than | 29 |
one or more | 29 |
are similar to | 29 |
the guidelines for | 29 |
management of respiratory | 29 |
in the same | 29 |
pneumococcal disease in | 29 |
and in the | 29 |
mortality in patients | 29 |
the ability to | 28 |
study of the | 28 |
clinical characteristics of | 28 |
in combination with | 28 |
common causes of | 28 |
the most commonly | 28 |
treatment of community | 28 |
the frequency of | 28 |
with communityacquired pneumonia | 28 |
intensive care units | 28 |
of patients who | 28 |
with a macrolide | 28 |
have also been | 28 |
infections of the | 28 |
children and adults | 28 |
of invasive pneumococcal | 28 |
the likelihood of | 28 |
mean roc auc | 28 |
who do not | 28 |
treatment should be | 28 |
have not been | 28 |
the patient is | 28 |
risk factors and | 28 |
respiratory viruses in | 28 |
diffuse alveolar damage | 28 |
the respiratory system | 28 |
with regard to | 28 |
the diagnosis is | 28 |
bone marrow transplant | 28 |
the mortality rate | 28 |
streptococcus pneumoniae in | 28 |
in one study | 28 |
japanese respiratory society | 28 |
and the presence | 27 |
be used for | 27 |
of influenza virus | 27 |
use of a | 27 |
pleural fl uid | 27 |
at risk for | 27 |
associated with increased | 27 |
of morbidity and | 27 |
adults and children | 27 |
and should be | 27 |
human immunodeficiency virus | 27 |
the appearance of | 27 |
chronic respiratory disease | 27 |
disease in the | 27 |
patients in whom | 27 |
global burden of | 27 |
with viral pneumonia | 27 |
in dogs and | 27 |
of acute respiratory | 27 |
haemophilus influenzae type | 27 |
valent pneumococcal conjugate | 27 |
e g e | 27 |
may be present | 27 |
a recent study | 27 |
at high risk | 27 |
pneumoniae urinary antigen | 27 |
for the prevention | 27 |
in a recent | 27 |
to have a | 26 |
were identified in | 26 |
thoracic society consensus | 26 |
of bal fluid | 26 |
the world health | 26 |
and risk factors | 26 |
all of the | 26 |
dogs and cats | 26 |
can be found | 26 |
infection in children | 26 |
the emergence of | 26 |
infection in the | 26 |
to be more | 26 |
if there is | 26 |
the occurrence of | 26 |
to assess the | 26 |
consensus guidelines on | 26 |
the centers for | 26 |
society consensus guidelines | 26 |
sensitivity and specificity | 26 |
patients in the | 26 |
found to be | 26 |
pneumonia should be | 26 |
to evaluate the | 26 |
patients with covid | 26 |
pleuritic chest pain | 26 |
viral pneumonia in | 26 |
to improve the | 26 |
east respiratory syndrome | 26 |
in recent years | 26 |
in hospitalized children | 26 |
appear to be | 26 |
have been developed | 26 |
to reduce the | 26 |
with pneumonia in | 26 |
associated with pneumonia | 26 |
this study was | 26 |
in of cases | 26 |
of blood cultures | 26 |
in the course | 26 |
mg kg once | 26 |
an influenza pandemic | 26 |
middle east respiratory | 26 |
with cystic fibrosis | 26 |
high prevalence of | 25 |
systematic review of | 25 |
and young children | 25 |
the effects of | 25 |
use of the | 25 |
e mg kg | 25 |
clinical diagnosis of | 25 |
the current study | 25 |
intravenous injection or | 25 |
and may be | 25 |
injection or drip | 25 |
of patients hospitalized | 25 |
is likely to | 25 |
occur in the | 25 |
pneumonia can be | 25 |
duration of therapy | 25 |
if the patient | 25 |
chronic lung disease | 25 |
approved by the | 25 |
the japanese respiratory | 25 |
in adults with | 25 |
is recommended for | 25 |
results of a | 25 |
infections caused by | 25 |
in the setting | 25 |
influenza virus infection | 25 |
for infection with | 25 |
type i pneumonocytes | 25 |
the site of | 25 |
may be the | 25 |
should be avoided | 25 |
the setting of | 25 |
and patients with | 25 |
it is possible | 25 |
than in the | 25 |
the emergency department | 25 |
bacterial pneumonia is | 25 |
for at least | 25 |
when there is | 25 |
to pneumococcal proteins | 25 |
all patients with | 25 |
after the onset | 24 |
the tracheobronchial tree | 24 |
of respiratory infectious | 24 |
was the most | 24 |
of the pulmonary | 24 |
may be a | 24 |
guidelines by the | 24 |
requiring intensive care | 24 |
studies have shown | 24 |
with a high | 24 |
nature of the | 24 |
the case of | 24 |
and respiratory syncytial | 24 |
may result in | 24 |
can occur in | 24 |
and viral pneumonia | 24 |
the causative agent | 24 |
the era of | 24 |
it is also | 24 |
patients with an | 24 |
refer to the | 24 |
shown to be | 24 |
with community acquired | 24 |
within the first | 24 |
the leading cause | 24 |
of the literature | 24 |
has been used | 24 |
pneumonia may be | 24 |
use of antibiotics | 24 |
causes of death | 24 |
those with severe | 24 |
a sensitivity of | 24 |
the patient has | 24 |
the availability of | 24 |
high risk of | 24 |
a study of | 24 |
presence of a | 24 |
kg once a | 24 |
than months of | 24 |
burden of disease | 24 |
children with severe | 24 |
in the respiratory | 24 |
that may be | 24 |
the involvement of | 24 |
was defined as | 24 |
the etiologic agent | 24 |
of infection with | 24 |
of hospital stay | 24 |
be combined with | 24 |
should be combined | 23 |
addition to the | 23 |
is more common | 23 |
of the virus | 23 |
h n influenza | 23 |
is seen in | 23 |
be present in | 23 |
ct findings in | 23 |
infants and young | 23 |
may occur in | 23 |
important cause of | 23 |
do not have | 23 |
a macrolide or | 23 |
aspiration pneumonia in | 23 |
is a risk | 23 |
the highest mean | 23 |
ill patients with | 23 |
to hospital with | 23 |
and septic shock | 23 |
of cap is | 23 |
the pleural surface | 23 |
type of pneumonia | 23 |
in case of | 23 |
year of age | 23 |
respect to the | 23 |
the clinical presentation | 23 |
was found in | 23 |
common in the | 23 |
pour le diagnostic | 23 |
children aged years | 23 |
an increased risk | 23 |
controlled trial of | 23 |
any of the | 23 |
practice guidelines by | 23 |
less than years | 23 |
as previously described | 23 |
to identify the | 23 |
the lungs of | 23 |
in the hospital | 23 |
length of hospital | 23 |
of the trachea | 23 |
the early stages | 23 |
by the presence | 23 |
hyperplasia of type | 23 |
to that of | 23 |
pneumonia among children | 23 |
large number of | 23 |
thickening of the | 23 |
listed in table | 23 |
of age in | 23 |
the present study | 23 |
are caused by | 23 |
the fact that | 23 |
occurs in the | 23 |
mycoplasma pneumoniae and | 23 |
streptococcus pneumoniae and | 22 |
cause of community | 22 |
to the lung | 22 |
is similar to | 22 |
results of the | 22 |
can lead to | 22 |
a randomized controlled | 22 |
practice guidelines for | 22 |
be used in | 22 |
that can be | 22 |
risk of pneumonia | 22 |
of infectious diseases | 22 |
surface of the | 22 |
is also a | 22 |
in older children | 22 |
is a major | 22 |
critical review of | 22 |
on chest radiograph | 22 |
are likely to | 22 |
in the era | 22 |
in which there | 22 |
in some patients | 22 |
high incidence of | 22 |
there has been | 22 |
symptoms such as | 22 |
the immunocompromised host | 22 |
management of pneumonia | 22 |
society guidelines for | 22 |
it can be | 22 |
of respiratory syncytial | 22 |
accordance with the | 22 |
associated with severe | 22 |
children hospitalized with | 22 |
and outcome of | 22 |
als to pneumococcal | 22 |
pneumonia is an | 22 |
study of patients | 22 |
in the initial | 22 |
may be useful | 22 |
on chest x | 22 |
of the world | 22 |
or absence of | 22 |
early stages of | 22 |
be used as | 22 |
and lower respiratory | 22 |
secondary bacterial infection | 22 |
an underlying disease | 22 |
treatment of cap | 22 |
severely ill patients | 22 |
chez les patients | 22 |
children in the | 22 |
tract infection in | 22 |
patients with pneumococcal | 22 |
the alveolar walls | 22 |
presence or absence | 22 |
childhood pneumonia in | 22 |
for the detection | 22 |
an important role | 21 |
patients hospitalized for | 21 |
there have been | 21 |
clinical signs and | 21 |
of hospitalized patients | 21 |
a risk of | 21 |
depends on the | 21 |
of mycoplasma pneumoniae | 21 |
was approved by | 21 |
proportion of patients | 21 |
viral infection in | 21 |
lower respiratory infections | 21 |
virus infections in | 21 |
or more of | 21 |
to of cases | 21 |
rapid diagnosis of | 21 |
of at least | 21 |
many of the | 21 |
the combination of | 21 |
other causes of | 21 |
of age and | 21 |
in clinical practice | 21 |
are needed to | 21 |
in the pediatric | 21 |
an important cause | 21 |
a day or | 21 |
randomised controlled trial | 21 |
this drug is | 21 |
the thoracic cavity | 21 |
days after the | 21 |
with severe community | 21 |
incidence and mortality | 21 |
of the study | 21 |
the context of | 21 |
bacterial pneumonia in | 21 |
adults with hospital | 21 |
viral infections in | 21 |
primary viral pneumonia | 21 |
may be associated | 21 |
the epidemiology of | 21 |
pneumonia associated with | 21 |
acute respiratory infections | 21 |
been reported to | 21 |
with and without | 21 |
a series of | 21 |
in adults and | 21 |
aspiration pneumonia is | 21 |
of pneumonia are | 21 |
the inflammatory process | 21 |
as high as | 21 |
have been identified | 21 |
viruses and bacteria | 21 |
treatment of pneumonia | 21 |
a first choices | 21 |
the rate of | 21 |
in the alveolar | 21 |
is necessary to | 21 |
g iv q | 21 |
we did not | 21 |
is not necessary | 21 |
of the patient | 21 |
in the pulmonary | 21 |
at increased risk | 21 |
bronchoalveolar lavage fluid | 21 |
should be obtained | 21 |
on chest radiographs | 20 |
the clinical features | 20 |
in domestic animals | 20 |
in the context | 20 |
diseases in children | 20 |
of this study | 20 |
of severe community | 20 |
major cause of | 20 |
characterized by the | 20 |
and mycoplasma pneumoniae | 20 |
lesions in the | 20 |
derived from the | 20 |
recent studies have | 20 |
and design of | 20 |
the section on | 20 |
should be started | 20 |
the pulmonary parenchyma | 20 |
of pleural effusion | 20 |
are shown in | 20 |
in the differential | 20 |
this type of | 20 |
management of cap | 20 |
sputum gram stain | 20 |
infection in adults | 20 |
viral pneumonia is | 20 |
the level of | 20 |
a common cause | 20 |
with chronic respiratory | 20 |
assessment of the | 20 |
damage to the | 20 |
caused by s | 20 |
as a rule | 20 |
and aspiration pneumonia | 20 |
into the lungs | 20 |
admission to the | 20 |
in patients hospitalized | 20 |
data suggest that | 20 |
in about of | 20 |
was used to | 20 |
used to treat | 20 |
and bacterial pneumonia | 20 |
that have been | 20 |
to of patients | 20 |
and critical review | 20 |
the performance of | 20 |
diseases of the | 20 |
is most commonly | 20 |
hantavirus pulmonary syndrome | 20 |
en cas de | 20 |
and frequency of | 20 |
children with pneumococcal | 20 |
which can be | 20 |
lower respiratory infection | 20 |
hospitalized with influenza | 20 |
antibiotic therapy in | 20 |
the study period | 20 |
assessment of severity | 20 |
patients with pulmonary | 20 |
multinucleated giant cells | 20 |
in children under | 20 |
g times a | 20 |
immune response to | 20 |
chest radiographs are | 19 |
the most frequently | 19 |
been described in | 19 |
may be more | 19 |
in infants with | 19 |
are characterized by | 19 |
randomized controlled trials | 19 |
differences in the | 19 |
in the current | 19 |
the upper lobes | 19 |
to the development | 19 |
cause of cap | 19 |
in the present | 19 |
be found in | 19 |
patients with aids | 19 |
pneumonia as a | 19 |
etiologic diagnosis of | 19 |
syncytial virus infection | 19 |
considered in the | 19 |
a decrease in | 19 |
of pneumococcal conjugate | 19 |
the lung and | 19 |
to conception and | 19 |
a day second | 19 |
requiring mechanical ventilation | 19 |
streptococcus pneumoniae urinary | 19 |
cirrhotic patients with | 19 |
contributed to conception | 19 |
in a large | 19 |
also be considered | 19 |
pediatric intensive care | 19 |
conception and design | 19 |
the nature of | 19 |
an outbreak of | 19 |
be noted that | 19 |
lower lung fields | 19 |
tumor necrosis factor | 19 |
understanding of the | 19 |
of severe sepsis | 19 |
pneumonia is not | 19 |
types of pneumonia | 19 |
to secondary bacterial | 19 |
which may be | 19 |
involvement of the | 19 |
mg kg twice | 19 |
it is difficult | 19 |
and pleural effusion | 19 |
kg twice a | 19 |
identification of a | 19 |
the formation of | 19 |
mechanically ventilated patients | 19 |
often associated with | 19 |
for those with | 19 |
should be noted | 19 |
during an influenza | 19 |
in hong kong | 19 |
children with influenza | 19 |
for patients who | 19 |
design of study | 19 |
such as those | 19 |
interpretation of results | 19 |
study reported that | 19 |
samples from patients | 19 |
this age group | 19 |
patients without pneumonia | 19 |
clinical features and | 19 |
caused by streptococcus | 19 |
randomized clinical trial | 19 |
committee of the | 19 |
the american thoracic | 19 |
which there is | 19 |
between the two | 19 |
by streptococcus pneumoniae | 19 |
parts of the | 18 |
in immunocompetent adults | 18 |
congenital heart disease | 18 |
of patients in | 18 |
based on a | 18 |
roc auc score | 18 |
are more likely | 18 |
the interpretation of | 18 |
development of pneumonia | 18 |
the conducting system | 18 |
children older than | 18 |
in patients admitted | 18 |
of the children | 18 |
is the leading | 18 |
a risk factor | 18 |
was detected in | 18 |
associated with influenza | 18 |
are listed in | 18 |
as a consequence | 18 |
with lower respiratory | 18 |
because of their | 18 |
mortality in the | 18 |
for severe cap | 18 |
of the bronchial | 18 |
the immune response | 18 |
of antimicrobial therapy | 18 |
the nasal mucosa | 18 |
segments of the | 18 |
in the pathogenesis | 18 |
acquired pneumonia with | 18 |
and mechanical ventilation | 18 |
nasal cavity and | 18 |
are susceptible to | 18 |
appearance of the | 18 |
extracorporeal membrane oxygenation | 18 |
in the clinical | 18 |
small number of | 18 |
the presence or | 18 |
microbial etiology of | 18 |
in the usa | 18 |
infection in a | 18 |
chest radiograph is | 18 |
primary ciliary dyskinesia | 18 |
a complication of | 18 |
allergic bronchopulmonary aspergillosis | 18 |
invasive pulmonary aspergillosis | 18 |
antibiotics should be | 18 |
infectious disease society | 18 |
are summarized in | 18 |
on the results | 18 |
factors such as | 18 |
immunocompromised patients with | 18 |
of influenza in | 18 |
can be identified | 18 |
patients with bacteremic | 18 |
in south africa | 18 |
the british thoracic | 18 |
evaluation of a | 18 |
there is an | 18 |
lead to a | 18 |
severe adv pneumonia | 18 |
characteristics of the | 18 |
systolic blood pressure | 18 |
were detected in | 18 |
in a prospective | 18 |
the first days | 18 |
severity of the | 18 |
urinary antigen tests | 18 |
that patients with | 18 |
are at risk | 18 |
blood cultures are | 18 |
of the pneumonia | 18 |
the radiographic features | 18 |
should be conducted | 18 |
for prevention of | 18 |
in conjunction with | 18 |
diseases such as | 18 |
in dogs with | 18 |
for management of | 18 |
be due to | 18 |
for respiratory viruses | 18 |
and pseudomonas aeruginosa | 18 |
diagnosis of cap | 18 |
a large number | 18 |
is a rare | 18 |
marrow transplant recipients | 18 |
and etiology of | 18 |
and a macrolide | 18 |
to occur in | 18 |
in patients in | 18 |
risk patients with | 18 |
other types of | 18 |
pleural effusions are | 18 |
adult respiratory distress | 18 |
although it is | 18 |
has been associated | 18 |
early in the | 18 |
the administration period | 18 |
are present in | 18 |
in relation to | 18 |
contribute to the | 18 |
more than of | 17 |
a definitive diagnosis | 17 |
management of severe | 17 |
human parainfluenza virus | 17 |
by the infectious | 17 |
the idsa ats | 17 |
of all patients | 17 |
diagnosis of community | 17 |
surrounded by a | 17 |
similar to the | 17 |
stem cell transplantation | 17 |
mycoplasma pneumoniae infection | 17 |
may present with | 17 |
commonly caused by | 17 |
pneumonia in immunocompetent | 17 |
detection of respiratory | 17 |
idsa ats guidelines | 17 |
empyema in children | 17 |
care unit admission | 17 |
particularly in the | 17 |
of atypical pneumonia | 17 |
with risk factors | 17 |
cause of morbidity | 17 |
in a child | 17 |
nucleic acid amplification | 17 |
segment of the | 17 |
all cases of | 17 |
bacteria such as | 17 |
high levels of | 17 |
caused by viruses | 17 |
symptoms and signs | 17 |
associated with lower | 17 |
for all patients | 17 |
the most likely | 17 |
all age groups | 17 |
most of these | 17 |
the trachea and | 17 |
in the right | 17 |
of the host | 17 |
of pneumonia was | 17 |
the patients with | 17 |
in the s | 17 |
widespread use of | 17 |
risk of resistant | 17 |
into the alveolar | 17 |
were more likely | 17 |
in the winter | 17 |
children less than | 17 |
years or older | 17 |
for severe community | 17 |
with pneumonia were | 17 |
burden of pneumonia | 17 |
pediatric infectious diseases | 17 |
associated with an | 17 |
the pattern of | 17 |
day second choices | 17 |
in older adults | 17 |
of the organism | 17 |
level iii evidence | 17 |
pathogens such as | 17 |
in a study | 17 |
may be necessary | 17 |
and staphylococcus aureus | 17 |
diagnostic accuracy of | 17 |
important role in | 17 |
acute respiratory illness | 17 |
for this reason | 17 |
patients with cystic | 17 |
it is often | 17 |
aged years or | 17 |
the alveolar space | 17 |
mild to moderate | 17 |
in the future | 17 |
results from the | 17 |
based on clinical | 17 |
were found to | 17 |
of risk factors | 17 |
reported that the | 17 |
according to a | 17 |
caused by influenza | 17 |
used in the | 17 |
syncytial virus in | 17 |
it is a | 17 |
inflammation of the | 17 |
have been associated | 17 |
patients with viral | 17 |
the global burden | 17 |
in whom the | 17 |
in primary care | 17 |
an intensive care | 17 |
with pneumonia and | 17 |
patients with bacterial | 17 |
of antimicrobial agents | 17 |
not be used | 17 |
severe sepsis and | 17 |
for mechanical ventilation | 17 |
treatment of the | 17 |
occurring in the | 17 |
resistant streptococcus pneumoniae | 17 |
the effectiveness of | 17 |
mechanical ventilation and | 17 |
to a lesser | 17 |
the lesions are | 17 |
of respiratory infections | 17 |
in comparison with | 17 |
needs to be | 17 |
stain and culture | 17 |
obtained from the | 17 |
gram stain and | 17 |
a role in | 17 |
children and adolescents | 17 |
in the most | 17 |
compared with the | 17 |
infection in patients | 17 |
located in the | 17 |
for hospitalized patients | 17 |
have been described | 16 |
respiratory tract in | 16 |
at the same | 16 |
complications such as | 16 |
be the most | 16 |
part of a | 16 |
those in whom | 16 |
to discriminate between | 16 |
requiring hospitalization among | 16 |
episodes per person | 16 |
even in the | 16 |
a systematic analysis | 16 |
the same time | 16 |
patients presenting with | 16 |
respiratory viral infections | 16 |
infection due to | 16 |
pneumonia is suspected | 16 |
presence of an | 16 |
h or more | 16 |
in otherwise healthy | 16 |
can result in | 16 |
cells in the | 16 |
such as pseudomonas | 16 |
reported in the | 16 |
patients infected with | 16 |
the potential to | 16 |
the lungs and | 16 |
of death from | 16 |
of antimicrobial drug | 16 |
to the section | 16 |
thought to be | 16 |
initial management of | 16 |
is an alternative | 16 |
of bacterial infection | 16 |
of the immune | 16 |
total wbc count | 16 |
in the incidence | 16 |
the benefit of | 16 |
cases of severe | 16 |
and streptococcus pneumoniae | 16 |
administration of antimicrobial | 16 |
from the lower | 16 |
the evaluation of | 16 |
factors for infection | 16 |
therapy in patients | 16 |
of the illness | 16 |
a comparison of | 16 |
should be managed | 16 |
a lesser extent | 16 |
large numbers of | 16 |
prise en charge | 16 |
described in the | 16 |
of the initial | 16 |
a respiratory fluoroquinolone | 16 |
year prospective study | 16 |
of chronic obstructive | 16 |
observed in the | 16 |
pneumonia incidence and | 16 |
impact of the | 16 |
upper and lower | 16 |
etiology of childhood | 16 |
mg kg day | 16 |
this is a | 16 |
hematopoietic stem cell | 16 |
np carriage of | 16 |
in acute respiratory | 16 |
as an alternative | 16 |
the lower airways | 16 |
studies are needed | 16 |
the utility of | 16 |
for severe pneumonia | 16 |
pneumonia and non | 16 |
of more than | 16 |
and specificity of | 16 |
on chest radiography | 16 |
among children with | 16 |
to patients with | 16 |
diagnosis is made | 16 |
case fatality rate | 16 |
is present in | 16 |
the microbial etiology | 16 |
for influenza a | 16 |
should always be | 16 |
none of the | 16 |
a prediction rule | 16 |
is not a | 16 |
pneumonia has been | 16 |
clinical signs of | 16 |
as many as | 16 |
course of the | 16 |
of these organisms | 16 |
more than one | 16 |
of pneumonia caused | 16 |
society and the | 16 |
be useful in | 16 |
at risk of | 16 |
a randomized trial | 16 |
in all patients | 16 |
bronchial wall thickening | 16 |
pneumonia is characterized | 16 |
with bacteremic pneumococcal | 16 |
has been described | 16 |
pneumonia in infants | 16 |
several studies have | 16 |
the perch study | 16 |
have suggested that | 16 |
the patient was | 16 |
in a small | 16 |
burden of community | 16 |
outcomes of patients | 16 |
examination of the | 16 |
findings in patients | 16 |
within days of | 16 |
reported to be | 16 |
protected specimen brush | 16 |
respiratory disease in | 16 |
in the development | 16 |
treatment of influenza | 16 |
children years of | 16 |
presence of pneumonia | 16 |
tend to be | 16 |
in the case | 16 |
is responsible for | 16 |
available in the | 16 |
in the emergency | 16 |
of age with | 16 |
did not differ | 16 |
of pulmonary infection | 16 |
risk of complications | 16 |
in severe community | 16 |
patients with communityacquired | 16 |
can be observed | 15 |
the value of | 15 |
patients admitted with | 15 |
in response to | 15 |
to define the | 15 |
should be evaluated | 15 |
which is the | 15 |
compared to the | 15 |
pneumoniae is the | 15 |
is possible that | 15 |
bacterial pneumonia and | 15 |
antibiotic therapy is | 15 |
the pneumonia severity | 15 |
testing for respiratory | 15 |
out of the | 15 |
and influenza deaths | 15 |
in the outpatient | 15 |
pleural effusion and | 15 |
most common causes | 15 |
a child with | 15 |
study showed that | 15 |
antimicrobial drug should | 15 |
such as s | 15 |
among children in | 15 |
it is the | 15 |
frequent cause of | 15 |
the gross lesions | 15 |
of the normal | 15 |
the general population | 15 |
been used to | 15 |
patients with respiratory | 15 |
aspiration of gastric | 15 |
the most severe | 15 |
in north america | 15 |
severity of pneumonia | 15 |
may be used | 15 |
and acute respiratory | 15 |
half of the | 15 |
of bacteremic pneumococcal | 15 |
to make a | 15 |
each of the | 15 |
only a small | 15 |
among the most | 15 |
into the pleural | 15 |
the aspiration of | 15 |
united states and | 15 |
more severe disease | 15 |
high rates of | 15 |
treatment of patients | 15 |
in the pleural | 15 |
the extent of | 15 |
experiments were performed | 15 |
patients with copd | 15 |
of pneumonia etiology | 15 |
the association between | 15 |
usually associated with | 15 |
was higher in | 15 |
ministry of health | 15 |
a randomized clinical | 15 |
in lower respiratory | 15 |
mycoplasma pneumoniae in | 15 |
and haemophilus influenzae | 15 |
au cours des | 15 |
in a pandemic | 15 |
disease society of | 15 |
single or multiple | 15 |
pneumonia in an | 15 |
caused by mycoplasma | 15 |
and in those | 15 |
of a new | 15 |
disease due to | 15 |
management of hospital | 15 |
diagnosis of bacterial | 15 |
acquired pneumonia is | 15 |
in this article | 15 |
most patients with | 15 |
results from a | 15 |
in this age | 15 |
responsible for the | 15 |
severe pneumonia requiring | 15 |
sepsis and septic | 15 |
and legionella pneumophila | 15 |
of tuberculosis in | 15 |
disease associated with | 15 |
known to be | 15 |
of the followings | 15 |
the pleural cavity | 15 |
multiplex polymerase chain | 15 |
patients who had | 15 |
acute respiratory tract | 15 |
may have a | 15 |
of pulmonary infections | 15 |
respiratory failure and | 15 |
mechanical ventilation for | 15 |
and the infectious | 15 |
to oral therapy | 15 |
duration of mechanical | 15 |
in bal fluid | 15 |
in mechanically ventilated | 15 |
shown in table | 15 |
is the first | 15 |
influenza in children | 15 |
most common pathogens | 15 |
used as a | 15 |
mg e times | 15 |
involved in the | 15 |
outcomes in patients | 15 |
positive blood culture | 15 |
a case of | 15 |
episodes of pneumonia | 15 |
due to influenza | 15 |
the ability of | 15 |
severity of disease | 15 |
underlying medical conditions | 15 |
approach to the | 15 |
viruses in the | 15 |
in cirrhotic patients | 15 |
the immune system | 15 |
showed that the | 15 |
patients with risk | 15 |
within hours of | 15 |
of all cases | 15 |
and young adults | 15 |
also be seen | 15 |
a prospective observational | 15 |
a consequence of | 15 |
as soon as | 15 |
in the left | 15 |
can be treated | 15 |
it is likely | 15 |
during the early | 15 |
the characteristics of | 15 |
patients with underlying | 15 |
as a diagnostic | 15 |
prevention and control | 15 |
response to treatment | 15 |
only a few | 15 |
such as in | 15 |
patients with non | 15 |
that it is | 15 |
patients who were | 15 |
the syndromic rm | 15 |
commonly seen in | 15 |
have been shown | 15 |
thoracic society guidelines | 15 |
ranging from to | 15 |
should be taken | 14 |
cases of cap | 14 |
therapy in the | 14 |
with the exception | 14 |
with pneumococcal bacteremia | 14 |
not included in | 14 |
mycobacterium avium complex | 14 |
economic burden of | 14 |
for pneumococcal pneumonia | 14 |
absence of a | 14 |
prediction rule to | 14 |
is that of | 14 |
associated pneumonia and | 14 |
such as streptococcus | 14 |
age of the | 14 |
many of these | 14 |
pneumonia in adult | 14 |
pneumonia in young | 14 |
portions of the | 14 |
may be difficult | 14 |
was obtained from | 14 |
two of the | 14 |
blood urea nitrogen | 14 |
because of its | 14 |
assay for detection | 14 |
mm in diameter | 14 |
the most recent | 14 |
of antimicrobial resistance | 14 |
and mortality of | 14 |
been found to | 14 |
with septic shock | 14 |
such as chronic | 14 |
diagnosis can be | 14 |
such as a | 14 |
epithelial cells and | 14 |
acute interstitial pneumonia | 14 |
also been reported | 14 |
the choice of | 14 |
data on the | 14 |
need for mechanical | 14 |
the sensitivity of | 14 |
the fi rst | 14 |
have led to | 14 |
for the use | 14 |
of antibiotic treatment | 14 |
of bronchoalveolar lavage | 14 |
the virus is | 14 |
in vitro resistance | 14 |
considered in patients | 14 |
for use in | 14 |
of antibiotic resistance | 14 |
the hospital with | 14 |
antibiotic treatment in | 14 |
to be associated | 14 |
in association with | 14 |
between patients with | 14 |
and the risk | 14 |
combination antibiotic therapy | 14 |
are responsible for | 14 |
acquired pneumonia among | 14 |
pneumococcal conjugate vaccines | 14 |
high proportion of | 14 |
and outcomes in | 14 |
rule to identify | 14 |
tests for the | 14 |
be useful to | 14 |
whether or not | 14 |
patients with other | 14 |
can be caused | 14 |
and influenza a | 14 |
response to the | 14 |
of fever and | 14 |
for the development | 14 |
acquired bacterial pneumonia | 14 |
of cases and | 14 |
conditions such as | 14 |
a retrospective study | 14 |
a few days | 14 |
patients with vap | 14 |
prevention of ventilator | 14 |
throughout the world | 14 |
within h of | 14 |
with cap who | 14 |
all of these | 14 |
was identified in | 14 |
higher than in | 14 |
necrosis of the | 14 |
from intravenous to | 14 |
acute and chronic | 14 |
with a b | 14 |
and length of | 14 |
diagnosis of pulmonary | 14 |
respiratory society guidelines | 14 |
no difference in | 14 |
has been identified | 14 |
children under five | 14 |
derivation and validation | 14 |
level ii evidence | 14 |
because it is | 14 |
in the acute | 14 |
the clinical and | 14 |
of the above | 14 |
higher in the | 14 |
frequency of causative | 14 |
two types of | 14 |
and duration of | 14 |
the production of | 14 |
onset of illness | 14 |
identified in patients | 14 |
less likely to | 14 |
children with community | 14 |
of gastric contents | 14 |
the outpatient setting | 14 |
usually occurs in | 14 |
have been used | 14 |
in previously healthy | 14 |
acquisition of data | 14 |
in the last | 14 |
the surface of | 14 |
it is an | 14 |
risk factors of | 14 |
the spread of | 14 |
microscopic examination of | 14 |
pneumonia was defined | 14 |
of influenza and | 14 |
and is a | 14 |
causes of cap | 14 |
were collected from | 14 |
suspected of having | 14 |
has been the | 14 |
obstructive lung disease | 14 |
the exception of | 14 |
the united kingdom | 14 |
intravenous to oral | 14 |
influenza virus pneumonia | 14 |
well as in | 14 |
pneumonia in older | 14 |
human beings and | 14 |
other respiratory viruses | 14 |
pulmonary alveolar macrophages | 14 |
identification of the | 14 |
interstitial lung disease | 14 |
children admitted to | 14 |
suggest that the | 14 |
were included in | 14 |
the form of | 14 |
chest radiograph and | 14 |
radiographic features of | 14 |
tends to be | 14 |
white blood cells | 14 |
the source of | 14 |
diffi cult to | 14 |
an analysis of | 14 |
of the presence | 14 |
identified in the | 14 |
prospective observational study | 14 |
level i evidence | 14 |
may be indicated | 14 |
randomized trial of | 14 |
pneumonia can occur | 14 |
it is necessary | 14 |
they can be | 14 |
the pediatric infectious | 14 |
a score of | 14 |
to the intensive | 14 |
clinical presentation of | 14 |
prior to the | 14 |
with the highest | 14 |
pneumoniae and h | 14 |
infection caused by | 14 |
to increase the | 14 |
is not always | 14 |
wide range of | 14 |
mycoplasma pneumoniae pneumonia | 14 |
data from the | 14 |
under five years | 13 |
conjugate vaccine in | 13 |
are common in | 13 |
children with bacterial | 13 |
le diagnostic de | 13 |
is likely that | 13 |
committee on immunization | 13 |
with cap and | 13 |
study of community | 13 |
pneumonia in elderly | 13 |
the addition of | 13 |
of the model | 13 |
by influenza a | 13 |
pneumoniae and legionella | 13 |
in this chapter | 13 |
therapy for patients | 13 |
on gram staining | 13 |
of chest radiographs | 13 |
a day for | 13 |
in the literature | 13 |
interlobular septal thickening | 13 |
of combination therapy | 13 |
the interlobular septa | 13 |
in this group | 13 |
in both lungs | 13 |
pneumonia requiring intensive | 13 |
the initial management | 13 |
infection with a | 13 |
be selected in | 13 |
infections in patients | 13 |
plus a macrolide | 13 |
in adults in | 13 |
be taken into | 13 |
the contribution of | 13 |
acquired pneumonia community | 13 |
of the child | 13 |
in this case | 13 |
the percentage of | 13 |
respiratory failure in | 13 |
of cap and | 13 |
day course of | 13 |
america and the | 13 |
is a well | 13 |
those who are | 13 |
and respiratory failure | 13 |
are unable to | 13 |
studies suggest that | 13 |
are filled with | 13 |
le diagnostic des | 13 |
and more than | 13 |
de la maladie | 13 |
viruses such as | 13 |
bronchioles and alveoli | 13 |
be the result | 13 |
onset of fever | 13 |
treatment in patients | 13 |
could not be | 13 |
in severe pneumonia | 13 |
more of the | 13 |
also associated with | 13 |
of chronic bronchitis | 13 |
and children with | 13 |
acquired pneumonia the | 13 |
viral infections of | 13 |
with a history | 13 |
severe respiratory distress | 13 |
less than of | 13 |
in adults hospitalized | 13 |
added to the | 13 |
performance of the | 13 |
and classification of | 13 |
those with a | 13 |
cause of severe | 13 |
bal fluid total | 13 |
treatment of severe | 13 |
to estimate the | 13 |
did not have | 13 |
a case report | 13 |
the list of | 13 |
valent pneumococcal polysaccharide | 13 |
of disease study | 13 |
a clinical diagnosis | 13 |
low risk of | 13 |
the radiographic appearance | 13 |
with severe respiratory | 13 |
of this drug | 13 |
and human beings | 13 |
from all patients | 13 |
is no evidence | 13 |
be related to | 13 |
seen in other | 13 |
than that of | 13 |
of the right | 13 |
the upper airway | 13 |
the classification of | 13 |
detection of viral | 13 |
use of antimicrobial | 13 |
in the general | 13 |
the two groups | 13 |
antibiotics in the | 13 |
la prise en | 13 |
in approximately of | 13 |
a major cause | 13 |
of the incidence | 13 |
in respiratory samples | 13 |
a mortality rate | 13 |
diagnostic and therapeutic | 13 |
diagnosis of influenza | 13 |
respiratory tract is | 13 |
decrease in the | 13 |
study was conducted | 13 |
assay for the | 13 |
study of cases | 13 |
is classified as | 13 |
results in a | 13 |
significant differences in | 13 |
disease in children | 13 |
type and frequency | 13 |
signs of pneumonia | 13 |
mortality rate of | 13 |
that of a | 13 |
of a pandemic | 13 |
table shows the | 13 |
were used to | 13 |
management of communityacquired | 13 |
limited number of | 13 |
and b viruses | 13 |
areas of the | 13 |
alveolar macrophages and | 13 |
infections in adults | 13 |
diagnostic tests for | 13 |
the right lower | 13 |
hospitalization among u | 13 |
and control of | 13 |
portal of entry | 13 |
of a patient | 13 |
with respiratory failure | 13 |
the radiographic findings | 13 |
in pneumonia patients | 13 |
patients who do | 13 |
the chest x | 13 |
of interstitial pneumonia | 13 |
well as the | 13 |
continues to be | 13 |
more than hours | 13 |
administration period of | 13 |
regardless of the | 13 |
cases and controls | 13 |
interstitial pneumonia and | 13 |
with an influenza | 13 |
on the clinical | 13 |
have demonstrated that | 13 |
analysis of a | 13 |
children with cap | 13 |
pathogens in community | 13 |
with chronic lung | 13 |
may be considered | 13 |
is required for | 13 |
there were no | 13 |
were obtained from | 13 |
the process of | 13 |
the first hours | 13 |
should be collected | 13 |
can be useful | 13 |
infections such as | 13 |
roc auc scores | 13 |
of america and | 13 |
patients with ventilator | 13 |
that are not | 13 |
arterial blood gas | 13 |
during the course | 13 |
increased risk for | 13 |
simplex virus pneumonia | 13 |
over the past | 13 |
the acute respiratory | 13 |
of h n | 13 |
bone marrow transplantation | 12 |
initial antibiotic therapy | 12 |
particularly in patients | 12 |
systemic inflammatory response | 12 |
mediastinal lymph nodes | 12 |
of infection in | 12 |
day or g | 12 |
of type i | 12 |
streptococcus pneumoniae is | 12 |
associated with higher | 12 |
is considered to | 12 |
bacterial infection in | 12 |
respiratory tract samples | 12 |
children in developing | 12 |
in cattle and | 12 |
pneumonia during the | 12 |
of death and | 12 |
in all cases | 12 |
in invasive pneumococcal | 12 |
at mg kg | 12 |
the yield of | 12 |
well as a | 12 |
number of cases | 12 |
of the infectious | 12 |
treated with antibiotics | 12 |
to identify low | 12 |
management of adult | 12 |
be considered when | 12 |
found to have | 12 |
unilateral or bilateral | 12 |
in situ hybridization | 12 |
with the development | 12 |
children with non | 12 |
in a community | 12 |
leading to the | 12 |
of cases in | 12 |
antimicrobial therapy in | 12 |
in the blood | 12 |
urinary antigen detection | 12 |
majority of patients | 12 |
is common in | 12 |
the inhalation of | 12 |
in less than | 12 |
source of infection | 12 |
of children under | 12 |
pneumonia among adults | 12 |
may be of | 12 |
presented in table | 12 |
the authors declare | 12 |
the end of | 12 |
results in the | 12 |
exacerbations of chronic | 12 |
are those of | 12 |
quality of care | 12 |
with avian influenza | 12 |
be included in | 12 |
lung disease and | 12 |
are rarely seen | 12 |
in the netherlands | 12 |
fluid total wbc | 12 |
in the form | 12 |
acute respiratory infection | 12 |
a small number | 12 |
wide variety of | 12 |
young children with | 12 |
an improvement in | 12 |
an alternative to | 12 |
infiltrates on chest | 12 |
rules of antimicrobial | 12 |
severe pneumonia and | 12 |
is that the | 12 |
of nosocomial pneumonia | 12 |
clinical characteristics and | 12 |
positive predictive value | 12 |
were admitted to | 12 |
most cases of | 12 |
to identify patients | 12 |
of cap patients | 12 |
a pleural effusion | 12 |
diseases society and | 12 |
advisory committee on | 12 |
chain reaction for | 12 |
of the causative | 12 |
the purpose of | 12 |
do not require | 12 |
over the last | 12 |
treatment of acute | 12 |
critical care medicine | 12 |
respiratory tract symptoms | 12 |
peripheral blood eosinophilia | 12 |
at least two | 12 |
and there is | 12 |
for the first | 12 |
acute exacerbation of | 12 |
those with chronic | 12 |
in patients without | 12 |
pulmonary edema and | 12 |
the h n | 12 |
invasive mechanical ventilation | 12 |
but did not | 12 |
acquired pneumonia due | 12 |
and other respiratory | 12 |
with an increased | 12 |
of the data | 12 |
pandemic influenza a | 12 |
in young adults | 12 |
therapy can be | 12 |
with the use | 12 |
during a pandemic | 12 |
there was a | 12 |
who are at | 12 |
and antibiotic resistance | 12 |
further studies are | 12 |
guidelines for management | 12 |
features of the | 12 |
expressed on myeloid | 12 |
to respiratory failure | 12 |
the developing world | 12 |
h n infection | 12 |
adenovirus pneumonia in | 12 |
is most frequently | 12 |
and prevention of | 12 |
is in the | 12 |
the gold standard | 12 |
of a rapid | 12 |
the scope of | 12 |
among adults hospitalized | 12 |
the evolution of | 12 |
in urine samples | 12 |
is estimated to | 12 |
g once a | 12 |
than those without | 12 |
for respiratory pathogens | 12 |
in severe cap | 12 |
as pseudomonas aeruginosa | 12 |
and south america | 12 |
de la pcr | 12 |
an antimicrobial drug | 12 |
rather than a | 12 |
the quality of | 12 |
study indicated that | 12 |
staphylococcus aureus and | 12 |
etiology of cap | 12 |
a pathogen in | 12 |
american journal of | 12 |
and review of | 12 |
injury to the | 12 |
most common bacterial | 12 |
be admitted to | 12 |
for children with | 12 |
a first choice | 12 |
during the first | 12 |
who are severely | 12 |
such as fever | 12 |
and public health | 12 |
it is estimated | 12 |
is needed to | 12 |
quinolones should be | 12 |
and infectious diseases | 12 |
in the covid | 12 |
as the presence | 12 |
clinical and radiological | 12 |
rapid detection of | 12 |
exacerbation of chronic | 12 |
be performed in | 12 |
types of bacteria | 12 |
ct features of | 12 |
is not recommended | 12 |
on immunization practices | 12 |
leading to a | 12 |
they have no | 12 |
clinical outcomes in | 12 |
idiopathic pulmonary fibrosis | 12 |
are recommended for | 12 |
the causative organism | 12 |
g twice a | 12 |
ventilator associated pneumonia | 12 |
of pandemic influenza | 12 |
introduction of the | 12 |
criteria for severe | 12 |
ct findings of | 12 |
referred to hospital | 12 |
predictive value of | 12 |
a chest x | 12 |
those patients with | 12 |
older than years | 12 |
aspiration risk factors | 12 |
of the infection | 12 |
the causes of | 12 |
the results obtained | 12 |
for pneumonia in | 12 |
clinical and radiographic | 12 |
viral causes of | 12 |
can progress to | 12 |
of a novel | 12 |
clinical manifestations of | 12 |
are able to | 12 |
for the identification | 12 |
these types of | 12 |
first hours of | 12 |
be identified in | 12 |
erythrocyte sedimentation rate | 12 |
increase the risk | 12 |
can be made | 12 |
one third of | 12 |
with evidence of | 12 |
with air bronchogram | 12 |
from the lungs | 12 |
epidemiology and clinical | 12 |
most common in | 12 |
diagnostic testing is | 12 |
of parapneumonic effusions | 12 |
adult patients admitted | 12 |
of a single | 12 |
be difficult to | 12 |
in icu patients | 12 |
administration of antibiotics | 12 |
of chest radiography | 12 |
with suspected pneumonia | 12 |
that they have | 12 |
higher risk of | 12 |
the inflammatory response | 12 |
was performed using | 12 |
the study was | 12 |
the accuracy of | 12 |
older than months | 12 |
are presented in | 12 |
giant cell pneumonia | 12 |
on the right | 12 |
on the pleural | 12 |
of the severity | 12 |
associated with death | 12 |
to confirm the | 12 |
regions of the | 12 |
s and s | 12 |
pneumonia in hiv | 12 |
of antibiotics in | 12 |
with severe illness | 12 |
and so on | 12 |
but may be | 12 |
underlying lung disease | 12 |
diseases in the | 12 |
play a role | 12 |
can be obtained | 11 |
that there is | 11 |
acquired respiratory tract | 11 |
pulmonary lesions are | 11 |
of respiratory pathogens | 11 |
in comparison to | 11 |
organ transplant recipients | 11 |
group of patients | 11 |
a patient who | 11 |
as compared with | 11 |
the th day | 11 |
children with asthma | 11 |
a wide variety | 11 |
in the field | 11 |
development of a | 11 |
to those in | 11 |
recommended for patients | 11 |
as opposed to | 11 |
detection of influenza | 11 |
open lung biopsy | 11 |
more frequent in | 11 |
a lack of | 11 |
been developed to | 11 |
and the united | 11 |
influenza virus and | 11 |
an international derivation | 11 |
burden of childhood | 11 |
the lung in | 11 |
children with acute | 11 |
the association of | 11 |
a wide range | 11 |
is referred to | 11 |
taken into account | 11 |
treated as outpatients | 11 |
in the adult | 11 |
respiratory pathogens in | 11 |
the texture of | 11 |
in treatment of | 11 |
has been estimated | 11 |
systematic analysis for | 11 |
can be detected | 11 |
antimicrobial therapy for | 11 |
in the section | 11 |
significantly higher in | 11 |
health care workers | 11 |
as a complication | 11 |
and outcome in | 11 |
enrolled in the | 11 |
to an icu | 11 |
and clinical characteristics | 11 |
but is not | 11 |
middle lobe syndrome | 11 |
may be caused | 11 |
in patients presenting | 11 |
of children in | 11 |
tuberculous mycobacterium infection | 11 |
of adult patients | 11 |
has been a | 11 |
higher incidence of | 11 |
it has a | 11 |
be divided into | 11 |
patients with sars | 11 |
triggering receptor expressed | 11 |
duration of illness | 11 |
pneumonia severity on | 11 |
a literature review | 11 |
now streptococcus pneumoniae | 11 |
pneumonia is one | 11 |
term care facilities | 11 |
nursing home residents | 11 |
of the pneumococcal | 11 |
patients with and | 11 |
in healthy adults | 11 |
those with underlying | 11 |
to be considered | 11 |
tract infections and | 11 |
microorganisms that cause | 11 |
in the guidelines | 11 |
the right middle | 11 |
from children with | 11 |
those of the | 11 |
the middle and | 11 |
required for the | 11 |
not appear to | 11 |
international derivation and | 11 |
is used to | 11 |
were found in | 11 |
in the developing | 11 |
the lung microbiome | 11 |
human metapneumovirus infection | 11 |
admitted to a | 11 |
of disease and | 11 |
children and young | 11 |
in ventilated patients | 11 |
region of the | 11 |
for pneumonia and | 11 |
to be effective | 11 |
of respiratory infection | 11 |
on the th | 11 |
both lower lung | 11 |
require mechanical ventilation | 11 |
cap in the | 11 |
are rare in | 11 |
used for the | 11 |
pneumonia effect of | 11 |
a foreign body | 11 |
made based on | 11 |
most common pathogen | 11 |
bts guidelines for | 11 |
outbreak of severe | 11 |
incidence of community | 11 |
not associated with | 11 |
of respiratory failure | 11 |
cause of the | 11 |
has been found | 11 |
the etiologic diagnosis | 11 |
resolution ct findings | 11 |
moderate to severe | 11 |
of the underlying | 11 |
in the thoracic | 11 |
phase of the | 11 |
resistance to penicillin | 11 |
followed by a | 11 |
chest radiographs in | 11 |
severe pneumococcal pneumonia | 11 |
acquired pneumonia a | 11 |
pseudomonas aeruginosa and | 11 |
nosocomial pneumonia in | 11 |
the virus to | 11 |
in intubated patients | 11 |
of viral infections | 11 |
soluble triggering receptor | 11 |
of an acute | 11 |
with pulmonary infiltrates | 11 |
primary cause of | 11 |
pneumonia in this | 11 |
intranuclear inclusion bodies | 11 |
aspects of the | 11 |
acute and convalescent | 11 |
the selection of | 11 |
of septic shock | 11 |
interstitial pneumonia with | 11 |
is useful for | 11 |
the alveolar interstitium | 11 |
it must be | 11 |
who are hospitalized | 11 |
impact on the | 11 |
de la culture | 11 |
patients treated with | 11 |
is estimated that | 11 |
childhood pneumonia and | 11 |
blood gas analysis | 11 |
the advent of | 11 |
distribution of the | 11 |
to respiratory syncytial | 11 |
the relationship between | 11 |
pediatric patients with | 11 |
not necessary to | 11 |
of the pandemic | 11 |
more sensitive than | 11 |
this disease is | 11 |
of infection is | 11 |
in of the | 11 |
are in the | 11 |
organisms such as | 11 |
acquired pneumonia severity | 11 |
a group of | 11 |
children who are | 11 |
is found in | 11 |
pulmonary defense mechanisms | 11 |
empiric antibiotic therapy | 11 |
drotrecogin alfa activated | 11 |
spectrum of pulmonary | 11 |
it would be | 11 |
to make the | 11 |
were positive for | 11 |
clinical presentation and | 11 |
and influenza virus | 11 |
with severe sepsis | 11 |
in a hospital | 11 |
for icu admission | 11 |
tuberculosis in children | 11 |
consolidation in the | 11 |
enlarged lymph nodes | 11 |
be complicated by | 11 |
what is the | 11 |
hospitalized children with | 11 |
the pneumococcal conjugate | 11 |
be considered as | 11 |
about of cases | 11 |
of pneumonia cases | 11 |
are used to | 11 |
e g times | 11 |
antibiotic treatment is | 11 |
pneumonia and sepsis | 11 |
h n virus | 11 |
pneumococcal pneumonia is | 11 |
positive and negative | 11 |
this is the | 11 |
the causative pathogen | 11 |
is the best | 11 |
some of these | 11 |
those caused by | 11 |
a nursing home | 11 |
by the pediatric | 11 |
associated with mortality | 11 |
authors declare that | 11 |
antimicrobial susceptibility of | 11 |
the neonatal period | 11 |
the reference standard | 11 |
portion of the | 11 |
is the only | 11 |
empirical antimicrobial therapy | 11 |
of staphylococcus aureus | 11 |
host defense mechanisms | 11 |
the distribution of | 11 |
for predicting the | 11 |
is a highly | 11 |
there are several | 11 |
during the study | 11 |
diagnosis of respiratory | 11 |
and does not | 11 |
severe disease and | 11 |
care unit patients | 11 |
pores of kohn | 11 |
respiratory tract and | 11 |
of secondary bacterial | 11 |
pao fio ratio | 11 |
reduction in the | 11 |
have been published | 11 |
in those patients | 11 |
tract infections are | 11 |
human metapneumovirus and | 11 |
duration of antibiotic | 11 |
pleural effusion is | 11 |
and atypical pathogens | 11 |
on presentation to | 11 |
common in patients | 11 |
aged years and | 11 |
patients with the | 11 |
retrospective cohort study | 11 |
this form of | 11 |
on myeloid cells | 11 |
in those who | 11 |
increased susceptibility to | 11 |
of hospital admission | 11 |
to the severity | 11 |
one study of | 11 |
diagnosis of the | 11 |
to diagnose vap | 11 |
patients with cirrhosis | 11 |
are described in | 11 |
isolated from the | 11 |
is demonstrated as | 11 |
are available in | 11 |
to decrease the | 11 |
adults aged years | 11 |
in patients receiving | 11 |
and moraxella catarrhalis | 11 |
especially in the | 11 |
within a few | 11 |
presentation to hospital | 11 |
pneumonia related to | 11 |
obtained in exp | 11 |
defined as a | 11 |
pneumonia refers to | 11 |
acquired in the | 11 |
and antimicrobial susceptibility | 11 |
radiographic appearance of | 11 |
in only of | 11 |
in all species | 11 |
on the presence | 11 |
chronic heart disease | 11 |
in the normal | 11 |
receptor expressed on | 11 |
the criteria for | 11 |
in children less | 11 |
with other comorbidities | 11 |
of the population | 11 |
among the elderly | 11 |
five years of | 11 |
patients can be | 11 |
severity on presentation | 11 |
results were obtained | 11 |
and validation study | 11 |
has resulted in | 11 |
detected in of | 11 |
in children is | 11 |
not respond to | 11 |
pneumonia based on | 11 |
bacteria and viruses | 11 |
with increased risk | 11 |
the severity and | 11 |
result in a | 11 |
analysis of cases | 11 |
and is the | 11 |
regional lymph nodes | 11 |
has been suggested | 11 |
of choice for | 11 |
binax now streptococcus | 11 |
attributable mortality of | 11 |
radiographic evidence of | 11 |
to be an | 11 |
was observed in | 11 |
period of antimicrobial | 11 |
to the administration | 11 |
in the middle | 11 |
frequently seen in | 11 |
acute respiratory disease | 11 |
initial antimicrobial therapy | 10 |
performed on the | 10 |
radiographic findings in | 10 |
bacteria in the | 10 |
have been found | 10 |
etiology in children | 10 |
by using the | 10 |
was supported by | 10 |
fever and cough | 10 |
the causative agents | 10 |
with severe covid | 10 |
analysis of children | 10 |
the fl uid | 10 |
de la technique | 10 |
the past months | 10 |
influenza a infection | 10 |
were performed using | 10 |
conjugate vaccine against | 10 |
other forms of | 10 |
urinary antigen testing | 10 |
occurs in patients | 10 |
is essential to | 10 |
third of patients | 10 |
the incidence and | 10 |
and as a | 10 |
as the most | 10 |
of patients admitted | 10 |
of a macrolide | 10 |
studies have suggested | 10 |
in epidemiological studies | 10 |
ml clotted blood | 10 |
level of consciousness | 10 |
would be expected | 10 |
with moderate to | 10 |
a bacterial pneumonia | 10 |
and characteristics of | 10 |
may or may | 10 |
pneumonia and other | 10 |
and critical care | 10 |
children with underlying | 10 |
a leading cause | 10 |
the rest of | 10 |
mg kg e | 10 |
g tds iv | 10 |
of these infections | 10 |
modification of the | 10 |
due to pneumonia | 10 |
are resistant to | 10 |
access to the | 10 |
with a positive | 10 |
children with respiratory | 10 |
pneumonia in developing | 10 |
were able to | 10 |
they should be | 10 |
and consist of | 10 |
not have a | 10 |
is limited to | 10 |
of practice guidelines | 10 |
improved within days | 10 |
of infection and | 10 |
in the airways | 10 |
high morbidity and | 10 |
hospitalized for cap | 10 |
on a chest | 10 |
without hiv infection | 10 |
be based on | 10 |
of microorganisms that | 10 |
in the viral | 10 |
blood cultures in | 10 |
pneumonia in which | 10 |
tuberculosis in the | 10 |
a pilot study | 10 |
causes of respiratory | 10 |
risk of infection | 10 |
they do not | 10 |
respiratory distress and | 10 |
such as influenza | 10 |
pneumonia secondary to | 10 |
subglottic secretion drainage | 10 |
to predict the | 10 |
to the lungs | 10 |
the department of | 10 |
studies have reported | 10 |
with poorly defined | 10 |
by means of | 10 |
with underlying lung | 10 |